The post-pericardiotomy syndrome

Current Opinion in Pulmonary Medicine

Volumn 18, Issue 4, 2012, Pages 366-374

  Imazio, Massimo ^a  

^a MARIA VITTORIA HOSPITAL   (Italy)

Author keywords

aspirin; cardiac surgery; colchicine; corticosteroids; postpericardiotomy syndrome; prevention

Indexed keywords

ACETYLSALICYLIC ACID; AMINOTRANSFERASE; ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; COLCHICINE; CORTICOSTEROID; CREATINE KINASE; CREATININE; HEART ANTIBODY; IBUPROFEN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ACUTE CORONARY SYNDROME; BLEEDING; CORONARY ARTERY BLOOD FLOW; CREATININE BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; EVIDENCE BASED MEDICINE; FEVER; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART TAMPONADE; HOSPITAL COST; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; LUNG EMBOLISM; PATHOGENESIS; PERICARDIAL EFFUSION; PERICARDIOTOMY; PERICARDITIS; PERICARDIUM; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE COMPLICATION; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; RISK FACTOR; STANDARDIZATION; THORAX PAIN; THORAX RADIOGRAPHY; UNSPECIFIED SIDE EFFECT;

ADULT; ANTI-INFLAMMATORY AGENTS; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; COLCHICINE; HUMANS; POSTPERICARDIOTOMY SYNDROME; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84862220847     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32835311a2     Document Type: Review

References (37)

1. Finkelstein Y, Shemesh J, Mahlab K, et al. Colchicine for the prevention of postpericardiotomy syndrome. Herz 2002; 27:791-794.
2. Janton OH, Glover R, O'Neil TJ, et al. Results of the surgical treatment for mitral stenosis: Analysis of 100 consecutive cases. Circulation 1952; 6:321-333.
3. Ito T, Engle MA, Goldberg HP. Postpericardiotomy syndrome following surgery for nonrheumatic heart disease. Circulation 1958; 17:549-556.
4. Imazio M, Spodick DH, Brucato A, et al. Controversial issues in the management of pericardial diseases. Circulation 2010; 121:916-928.
5. Engle MA, Zabriskie JB, Senterfit LB, et al. Viral illness and the postpericardiotomy syndrome: A prospective study in children. Circulation 1980; 62:1151-1158.
6. Dressler W. The postmyocardial infarction syndrome. Arch Intern Med 1959; 103:28-42.
7. Robinson J, Brigden W. Immunological studies in the postcardiotomy syndrome. Br Med J 1963; 5359:706-709.
8. Van der Geld H. Antiheart antibodies in the postpericardiotomy and the postmyocardial-infarction syndromes. Lancet 1964; 18:617-621.
9. McCabe JC, Ebert PA, Engle MA, et al. Circulating heart-reactive antibodies in the postpericardiotomy syndrome. J Surg Res 1973; 14:158-164.
10. Kim S, Sahn SA. Postcardiac injury syndrome: An immunologic pleural fluid analysis. Chest 1996; 109:570-572.
11. Nomura Y, Yoshinaga M, Haraguchi T, et al. Relationship between the degree of injury at operation and the change in antimyosin antibody titer in the postpericardiotomy syndrome. Pediatr Cardiol 1994; 15:116-120.
12. Bartels C, Hönig R, Burger G, et al. The significance of anticardiolipin antibodies and antiheart muscle antibodies for the diagnosis of postpericardiotomy syndrome. Eur Heart J 1994; 15:1494-1499.
13. Hoffman M, Fried M, Jabareen F, et al. Antiheart antibodies in postpericardiotomy syndrome: Cause or epiphenomenon? A prospective, longitudinal pilot study. Autoimmunity 2002; 35:241-245.
14. Wessman DE, Stafford CM. The postcardiac injury syndrome: Case report and review of the literature. South Med J 2006; 99:309-314.
15. Lange RA, Hillis LD. Clinical practice. Acute pericarditis. N Engl J Med 2004; 351:2195-2202.
16. Imazio M, Trinchero R, Brucato A, et al., COPPS Investigators. COlchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS): A multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J 2010; 31:2749-2754.This is the largest multicenter, double-blind, placebo-controlled, randomized trial on the prevention of the postpericardiotomy syndrome by colchicine use.
17. Cabalka AK, Rosenblatt HM, Towbin JA, et al. Postpericardiotomy syndrome in pediatric heart transplant recipients. Immunologic characteristics. Tex Heart Inst J 1995; 22:170-176.
18. Hoit BD. Postcardiac injury syndrome. www.uptodate.com. [Accessed 30 December 2011]
19. Ritter G. Are we missing something? What is really the postcardiotomy syndrome? South Med J 2006; 99:206-207.
20. Imazio M, Brucato A, Rovere ME, et al. Contemporary features, risk factors, and prognosis of the postpericardiotomy syndrome. Am J Cardiol 2011; 108:1183-1187. This is the contemporary series on clinical presentation, risk factors, and prognosis of the postpericardiotomy syndrome.
21. Weitzman LB, Tinker WP, Kronzon I, et al. The incidence and natural history of pericardial effusion after cardiac surgery: An echocardiographic study. Circulation 1984; 69:506-511.
22. Horowitz MS, Schultz CS, Stinson EB, et al. Sensitivity and specificity of echocardiographic diagnosis of pericardial effusion. Circulation 1974; 50:239-247.
23. Meurin P, Tabet JY, Thabut G, et al., French Society of Cardiology. Nonsteroidal anti-inflammatory drug treatment for postoperative pericardial effusion: A multicenter randomized, double-blind trial. Ann Intern Med 2010; 152:137-143.This is the randomized trial on the use of diclofenac for the treatment of postoperative pericardial effusion.
24. Mott AR, Fraser CD Jr, Kusnoor AV, et al. The effect of short term prophylactic methylprednisolone on the incidence and severity of postpericardiotomy syndrome in children undergoing cardiac surgery with cardiopulmonary bypass. J Am Coll Cardiol 2001; 37:1700-1706.
25. Gill PJ, Forbes K, Coe JY. The effect of short-term prophylactic acetylsalicylic acid on the incidence of postpericardiotomy syndrome after surgical closure of atrial septal defects. Pediatr Cardiol 2009; 30:1061-1067.
26. Imazio M, Brucato A, Mayosi BM, et al. Medical therapy of pericardial diseases. Part I. Idiopathic and infectious pericarditis. J Cardiovasc Med (Hagerstown) 2010; 11:712-722.
27. Imazio M, Brucato A, Mayosi BM, et al. Medical therapy of pericardial diseases. Part II. Noninfectious pericarditis, pericardial effusion and constrictive pericarditis. J Cardiovasc Med (Hagerstown) 2010; 11:785-794.
28. Imazio M, Brucato A, Maestroni S, et al. Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: Implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation 2011; 123:1092-1097.This is the first prospective study evaluating the time course of C-reactive protein during acute pericarditis and its possible use to guide management.
29. Maisch B, Seferović PM, Ristić AD, et al., Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary; the task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology. Eur Heart J 2004; 25:587-610.
30. Imazio M, Brucato A, Cumetti D, et al. Corticosteroids for recurrent pericarditis: High versus low doses -a nonrandomized observation. Circulation 2008; 118:667-671.
31. Imazio M. Evaluation and management of pericarditis. Expert Rev Cardiovasc Ther 2011; 9:1221-1233.
32. Imazio M, Brucato A, Trinchero R, et al. Corticosteroid therapy for pericarditis: A double-edged sword. Nat Clin Pract Cardiovasc Med 2008; 5:118-119.
33. Imazio M, Brucato A, Trinchero R, et al. Colchicine for pericarditis: Hype or hope? Eur Heart J 2009; 30:532-539.
34. Imazio M, Brucato A, Maestroni S, et al. Risk of constrictive pericarditis after acute pericarditis. Circulation 2011; 124:1270-1275.This is the first prospective study evaluating the risk of developing constrictive pericarditis after acute pericarditis in a series of 500 consecutive cases.
35. Imazio M, Brucato A, Markel G, et al. Meta-analysis of randomized trials focusing on prevention of the postpericardiotomy syndrome. Am J Cardiol 2011; 108:575-579.This is the first meta-analysis on clinical trials for postpericardiotomy syndrome prevention.
36. Imazio M, Brucato A, Rovere ME, et al. Colchicine prevents early postoperative pericardial and pleural effusions. Am Heart J 2011; 162:527-532.This is the substudy of the COPPS trial showing efficacy and safety of colchicine for prevention of postoperative effusions regardless of the definition of the postpericardiotomy syndrome.
37. Imazio M, Brucato A, Ferrazzi P, et al., COPPS Investigators. Colchicine reduces postoperative atrial fibrillation: Results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation 2011; 124:2290-2295.